Zimmer Biomet Holdings Other accrued liabilities decreased by 15.1% to $1.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 25.9%, from $1.39B to $1.03B. Over 5 years (FY 2020 to FY 2025), Other accrued liabilities shows a downward trend with a -6.1% CAGR.
Significant fluctuations may indicate changes in business model, such as shifts in deferred revenue recognition or changes in short-term regulatory obligations.
This category includes miscellaneous short-term obligations that are not classified under accounts payable or accrued li...
Commonly used as a catch-all for short-term liabilities; varies by industry and business model.
current_liabilities_other_liabilities_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.48B | $1.44B | $1.32B | $1.12B | $1.03B | $1.16B | $1.42B | $1.07B | $1.28B | $1.30B | $1.55B | $1.39B | $1.39B | $1.54B | $1.39B | $1.39B | $1.53B | $1.49B | $1.22B | $1.03B |
| QoQ Change | — | -2.1% | -8.8% | -15.1% | -7.6% | +11.8% | +22.9% | -24.5% | +19.1% | +1.7% | +19.0% | -10.4% | +0.2% | +10.6% | -9.3% | +0.0% | +9.8% | -2.8% | -18.2% | -15.1% |
| YoY Change | — | — | — | — | -30.0% | -20.0% | +7.9% | -4.1% | +23.6% | +12.4% | +8.8% | +29.2% | +8.7% | +18.2% | -9.9% | +0.5% | +10.2% | -3.2% | -12.7% | -25.9% |